These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Electrical evaluation of the facial nerve in acoustic neuroma patients: preliminary comparison between transcranial magnetic coil stimulation and electroneurography.
    Author: Duckert LG, Höhmann D, DeMeester C.
    Journal: Am J Otol; 1992 Mar; 13(2):113-6. PubMed ID: 1599000.
    Abstract:
    Subclinical involvement of the facial nerve by acoustic neuromas may be identified preoperatively using conventional electroneurography (ENoG). The clinical application of extratemporal stimulation distal to the stylomastoid foramen is limited in these cases by the more proximal site of the lesion. Transcranial magnetic coil stimulation (MCS) is a noninvasive means by which the facial nerve is stimulated at the level of the motor cortex or the brain stem, before it enters the internal auditory canal. Topographically such an assessment may have more diagnostic relevance than other forms of electrical stimulation in acoustic neuroma patients. To test this theory the facial nerves of 20 patients with acoustic neuromas were stimulated using ENoG and MCS preoperatively and 1 week postoperatively. Stimulation parameters were comparable and included threshold and suprathreshold levels of stimulation while compound action potential amplitudes and early and late response latencies were monitored. Facial nerve function was assessed clinically using the Stennert grading system. All the patients had clinically normal facial nerve function preoperatively. Normative data suggested a close correlation between threshold and suprathreshold amplitudes generated by both ENoG and MCS. To the contrary, in the pathologic ears there was a higher incidence of stimulus response abnormality determined by MCS than by ENoG. A comparison of these data, tumor size, and postoperative results promotes further evaluation of MCS as a prognostic index in acoustic neuroma patients.
    [Abstract] [Full Text] [Related] [New Search]